Asuragen, Inc.

Asuragen is a fully integrated diagnostic company and molecular biology service provider, focused on molecular oncology and genetic diseases, with emphasis on microRNA (miRNA). Asuragen’s current diagnostic product portfolio consists of Signature® Oncology Testing products for Leukemia and KRAS and a FMR1 assay as well as industry leading controls and standards engineered using its patented Armored® RNA technology including custom Armored RNA constructs for licensees of its Armored RNA technology.

.